MedTrace Logo

Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection

NCT04849455 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-06-07

No results posted yet for this study

Summary

To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.

Conditions

  • Hepatic Resection
  • Acute Pain
  • Anesthesia
  • Anesthesia, Local

Interventions

DRUG

0.2% ropivacaine local anesthetic continuous erector spinae plane block

Treatment- continuous erector spinae block catheter followed by an infusion of ropivacaine 0.2% at 10ml automatic set bolus per 60 minute with 2ml/hr continuous infusion (12mls/hr total per catheter)

DRUG

0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block

Placebo- Superficially placed (taped to the surface) erector spinae block catheter with a ropivacaine 0.2% infusion at 0.1ml /hr

DRUG

Spinal Morphine

200-300 mcg of spinal morphine

Sponsors & Collaborators

Principal Investigators

  • Engy T Said, MD · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-24
Primary Completion
2023-05-01
Completion
2023-05-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04849455 on ClinicalTrials.gov